Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.71 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.44 |
| ▸ | PLCD1 | P51178 | 1/20 | 0.42 |
| ▸ | CAPN1 | P07384 | 2/20 | 0.41 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.41 |
| ▸ | CA12 | O43570 | 2/20 | 0.41 |
| ▸ | CA1 | P00915 | 2/20 | 0.41 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | CA9 | Q16790 | 2/20 | 0.41 |
| ▸ | FGF1 | P05230 | 1/20 | 0.41 |
| ▸ | FGF2 | P09038 | 1/20 | 0.41 |
| ▸ | VEGFA | P15692 | 1/20 | 0.41 |
| ▸ | HPSE | Q9Y251 | 1/20 | 0.41 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.39 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.39 |
| ▸ | CNR1 | P21554 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | ABL1 | P00519 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11983712 | 0.86 | TDP1 (0.51) | TDP1FOLH1PLCD1CAPN1CA12 | |
| SCHEMBL20123269 | 0.85 | TDP1 (0.50) | TDP1FOLH1PLCD1CAPN1CA12 | |
| SCHEMBL565396 | 0.84 | TDP1 (0.98) | TDP1FOLH1PLCD1CAPN1CA12 | |
| SCHEMBL9168421 | 0.84 | TDP1 (0.98) | TDP1FOLH1PLCD1CAPN1CA12 | |
| SCHEMBL9171752 | 0.83 | TDP1 (0.96) | TDP1FOLH1PLCD1CAPN1CA12 | |
| SCHEMBL18881123 | 0.83 | TDP1 (0.49) | TDP1FOLH1PLCD1CAPN1CA12 | |
| SCHEMBL13510665 | 0.83 | TDP1 (1.00) | TDP1FOLH1PLCD1CAPN1CA12 | |
| SCHEMBL564538 | 0.83 | TDP1 (1.00) | TDP1FOLH1PLCD1CAPN1CA12 | |
| SCHEMBL305707 | 0.83 | TDP1 (1.00) | TDP1FOLH1PLCD1CAPN1CA12 | |
| SCHEMBL305706 | 0.83 | TDP1 (1.00) | TDP1FOLH1PLCD1CAPN1CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200261363-A1 | LIPID CONSTRUCT FOR DELIVERY OF INSULIN TO A MAMMAL | SDG INC (US) | 2020-08-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200261363-A1 | LIPID CONSTRUCT FOR DELIVERY OF INSULIN TO A MAMMAL | INSR, IAPP, GPR119 | TDP1 4882/4885FOLH1 1165/4885PLCD1 1602/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.